Skip to content

Unravelling the cell subsets of osteonecrosis of the femoral head

Cellular dissection of the bone immune microenvironment in osteonecrosis of the femoral head

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN86670828
Enrollment
15
Registered
2026-02-10
Start date
2026-01-23
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with glucocorticoid-induced osteonecrosis of the femoral head Musculoskeletal Diseases

Interventions

This is a non-interventional, biological specimen research study. It involves the use of hip joint tissues that are routinely removed and discarded during standard total hip arthroplasty surgery from

Sponsors

Luoyang Orthopedic Hospital of Henan Province, Orthopedic Hospital of Henan Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Experimental group: Patients with femoral head necrosis undergoing THA surgery in our hospital 2. Control group: Patients with femoral neck fracture or hip osteoarthritis undergoing THA surgery in our hospital 3. Willingness to participate in the study and provision of signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with unclear diagnosis 2. Issues with sample quality:Biological samples with severe contamination or other problems during collection, transportation or preservation, which may affect the accuracy of experimental test results.Samples with insufficient quantity to meet the requirements of experimental detection, making them unsuitable for IHC assays. 3. Special populations and other conditions:Pregnant or lactating women. 4. Patients who have recently (within one month) used drugs that may affect experimental results. 5. Patients with severe systemic diseases such as heart, liver or kidney diseases, or those with mental illnesses, malignant tumors or other diseases that may affect research results or life expectancy.

Countries

China

Contacts

Public ContactYage Luo
L03790371@163.com+86 15038552124

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026